Acetylcysteine.
Research-backed compound with potential health benefits. Boosts glutathione, your body's main antioxidant. This helps protect your cells from damage. It's also an effective mucolytic, meaning it thins mucus to help clear your lungs.
Reviewed March 2026
Compound- Category
- Compound
What Acetylcysteine is, and what it does.
- Does it work
- Yes, for specific goals. Great for respiratory health during a cold and for liver support. As a general antioxidant, the evidence is solid but the benefits are backstage.
- How much to take
- 600-1200mg per day, often split into two doses. Higher doses are used for mental health research, but this is the sweet spot for general support.
- Time to feel it
- Mucus feels looser within a day or two. The glutathione side moves slower and shows up on a blood marker across two to four weeks rather than as a sensation.
- The first dose
- If you have lung congestion, you might notice things loosening up. For anything else, you won't feel a thing. It's not a stimulant.
- With regular use
- Stronger antioxidant defenses. Better resilience against cellular stress. Some studies suggest benefits for mood and compulsive behaviors, but that's still being investigated.
- How well tolerated
- Generally well tolerated. The sulfur smell is off-putting but harmless. Taking it with food helps with potential stomach issues.
- How it feels
- A silent worker. You don't feel it. Think of it as your body's cleanup crew working in the background, not a performance enhancer you notice immediately.
- The overlooked benefit
- Very little of the intact molecule survives the first pass through gut and liver. What rises in your blood is cysteine, and that is the part doing most of the work.
600 to 1,200mg a day is where Acetylcysteine works.
Source: Atkuri 2007 + Deepmala 2015 psych review
The proof, claim by claim.
What these words mean
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Acetylcysteine is documented in the library. The clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- Glutathione statusRandomised trial
- Mucus viscosity and clearanceMeta-analysis
4 more claims
- Antioxidant defence markersRandomised trial
- Oxidative stress after hard exerciseRandomised trial
- Sperm quality markers in menRandomised trial
- Cysteine supply to the transsulfuration pathwayNarrative review
Questions people ask about Acetylcysteine.
- Why does it smell so bad?
- Sulfur. It's a key part of the molecule and what makes it work. The smell means it's legit. Hold your nose and swallow.
4 more questions
- Is it safe to take every day?
- Yes, for most people. Standard doses (600-1200mg) have a good safety record for long-term use.
- Will it help with a hangover?
- Theoretically, by supporting the liver. Take it before drinking, not after. A better plan is to drink less and hydrate more.
- Best time to take it?
- On an empty stomach is best for absorption. If it upsets your stomach, take it with food. Consistency matters more than timing.
- Is this the same stuff used in hospitals?
- Yes. High-dose IV NAC is the gold standard antidote for Tylenol (acetaminophen) poisoning. This actually works.
Why these belong in the same formula, 20 pairings
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Cysteine is the rate-limiting substrate for glutathione synthesis, and N-acetylcysteine is a deacetylation step away from cysteine. Supplying it raises intracellular cysteine availability for glutamate-cysteine ligase, the first and controlling enzyme of the two-step synthesis. Oral glutathione itself is largely broken down to its constituent amino acids before absorption, so the two arrive at the same pool by different routes.
Glutathione is a tripeptide of glutamate, cysteine and glycine, so glycine is the third required substrate and can become limiting in older adults even when cysteine is plentiful. The combined glycine and N-acetylcysteine approach exists precisely because supplying one precursor without the other leaves synthesis constrained. This is stoichiometry rather than an interaction effect.
Glutamine is deamidated to glutamate, the third amino acid of the glutathione tripeptide and the partner cysteine is ligated to in the first synthesis step. In tissues with high glutamine turnover this supply route matters for how much glutathione can be assembled. The relationship is substrate provision, nothing more.
Glutathione peroxidases are selenoproteins that carry selenocysteine in the active site, and they are what actually spends glutathione to reduce peroxides. Raising glutathione without adequate selenium leaves the enzyme side of that pair under-supplied. The two sit on consecutive steps of the same defence.
Ascorbate and glutathione regenerate each other through the ascorbate-glutathione cycle, with glutathione reducing dehydroascorbate back to the active vitamin. Cysteine supplied as N-acetylcysteine therefore feeds a pool that ascorbate draws on. Both also keep thiol groups on other proteins in the reduced state.
Dihydrolipoate can reduce oxidised glutathione directly and can also spare cysteine by supporting its uptake into cells. The pairing therefore attacks the same pool from a synthesis and a regeneration angle at once. Both compounds carry free or reducible thiol chemistry, which is also why both smell and taste the way they do.
A free sulfhydryl group binds transition metals, and N-acetylcysteine is a documented chelator of copper. Regular high intake alongside copper could reduce how much of the mineral remains available. Spacing the two is the usual practical response, and this cuts both ways for anyone deliberately supplementing copper.
Thiol groups coordinate zinc, which is the basis of every zinc finger in the genome, so a free-thiol compound in the gut lumen can bind dietary zinc. The practical size of this effect at supplement doses has not been quantified. Taking the two at separate times avoids the question entirely.
Activated charcoal adsorbs small organic molecules non-selectively in the gut lumen, and N-acetylcysteine is exactly the kind of compound it binds. Taken together, less of the thiol is available for absorption. This is a general rule for charcoal and any oral active, not a special property of this pairing.
N-acetylcysteine is L-cysteine with an acetyl group on the amino nitrogen, added because free cysteine oxidises readily to cystine and is unstable in a capsule. Intestinal and hepatic deacetylases remove that group after absorption. The acetyl is a stability device, not a separate active feature.
Methionine feeds cysteine synthesis through the transsulfuration pathway by way of homocysteine and cystathionine, which is the body's own route to the amino acid. Supplying cysteine directly reduces the draw on that pathway. The two therefore converge on the same pool from opposite directions.
Both enzymes of transsulfuration, cystathionine beta-synthase and cystathionine gamma-lyase, require pyridoxal 5-phosphate as cofactor. Without adequate B6 the body's own conversion of homocysteine to cysteine slows. That makes B6 status part of the picture for anyone thinking about cysteine supply.
Betaine remethylates homocysteine back to methionine, pulling flux away from the transsulfuration branch that produces cysteine. N-acetylcysteine acts on the other side of that junction by supplying cysteine directly. The two therefore both touch homocysteine handling, from different arms.
S-adenosylmethionine is the allosteric activator of cystathionine beta-synthase, the committing step that routes homocysteine toward cysteine. Its concentration is one of the switches that decides whether one-carbon flux goes to remethylation or to thiol synthesis. N-acetylcysteine bypasses that regulation entirely.
Taurine is made from cysteine through cysteine dioxygenase and decarboxylation, so cysteine availability sits upstream of taurine synthesis. Supplying N-acetylcysteine feeds a pool that branches to both glutathione and taurine. Which branch dominates depends on cysteine dioxygenase activity, which is itself regulated by cysteine levels.
Sulfite oxidase, a molybdenum-dependent enzyme, handles the sulfite generated as cysteine is catabolised. Higher sulfur amino acid intake raises the load on that step. Molybdenum status is therefore part of normal sulfur handling rather than a partner with any independent action here.
Myo-inositol and N-acetylcysteine are routinely combined in formulas aimed at normal ovulatory cycles and insulin signalling, where each is studied separately for those measures. Inositol works as a second messenger precursor while N-acetylcysteine works through thiol redox chemistry, so the mechanisms do not overlap. The pairing rests on convention and on separate single-ingredient trials, not on a head-to-head combination study cited here.
One report examined vitamin D and N-acetylcysteine supplementation together against mood, cognition and blood biomarkers. It reports associations, which are not causal findings, and the two ingredients were assessed as a pair. Their mechanisms, nuclear receptor signalling and thiol supply, are unrelated.
Silymarin supports hepatocyte glutathione content and membrane integrity, while N-acetylcysteine supplies the limiting amino acid for glutathione synthesis. They arrive at liver antioxidant capacity by different routes and are commonly formulated together for that reason. No trial of the specific combination is cited here.
NAC and acetylcysteine name the same molecule, N-acetyl-L-cysteine, under a common abbreviation and its full chemical name. Anything true of one is true of the other. This row exists so the two catalogue entries are not read as separate ingredients that could be stacked.
Nothing specific on file for Acetylcysteine. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Acetylcysteine actually does.
N-acetylcysteine is the amino acid cysteine with an added chemical cap that keeps it from oxidizing during manufacturing and storage.
3 more mechanisms
Once absorbed, enzymes in the liver and cells remove that cap to release plain cysteine, and most of what this ingredient does is really cysteine's doing.
Cysteine is the ingredient your cells need most to build glutathione, their main internal antioxidant, so how much cysteine is available directly limits how much glutathione a cell can make.
The reactive sulfur group in this molecule can break certain chemical bonds, which is the basis for its long use in thinning thick mucus.
Where Acetylcysteine comes from.
It starts as the amino acid cysteine, which is either grown by bacteria in a fermentation tank or pulled out of keratin such as feathers. A small acetyl group is then attached to make it stable in a capsule, and the powder is purified and dried.
What this route gives you
The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.
5 steps on record
L-cysteine reaches the market by two distinct routes: microbial fermentation using engineered Escherichia coli or Corynebacterium on a sugar and sulfur source, and acid hydrolysis of keratin from duck feathers or human hair, which is still used in some regions. Vegan and kosher or halal certifications turn on which route was used.
The alpha-amino group of L-cysteine is acetylated, usually with acetic anhydride under controlled pH and temperature, protecting the thiol from oxidation during the reaction.
The product is crystallised from aqueous or alcoholic solution and washed to remove acetic acid residues, unreacted cysteine and the oxidised cystine by-product.
Material is assayed by titration or chromatography for purity and residual solvents, and checked to confirm the L-configuration was retained.
The dried crystals are encapsulated, compressed, blended into an effervescent base, or packed as bulk powder in a moisture-barrier container.
Many labels do not state which cysteine route was used, which is the detail that decides whether the material is plant-suitable.
Getting Acetylcysteine from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
4 more forms
The essence, in one line each.
- In a systematic review of trials in adult men, N-acetylcysteine supplementation improved exercise performance and antioxidant capacity, but showed no clear benefit for markers of muscle behavior or inflammation.Systematic review. Fernández-Lázaro et al., 2023 (Nutrients). PMID 37299425 ↗
7 more findings
- Pooling trials in men with a diagnosed fertility condition or low sperm quality measures, N-acetylcysteine supplementation was associated with higher sperm concentration, motility, and proportion of normally shaped sperm than control.Meta-analysis, in male with infertility or impaired semen parameters. Syarif et al., 2025 (Archivio Italiano di Urologia e Andrologia). PMID 40126496 ↗
- In a meta-analysis of 22 trials in women with a diagnosed hormonal condition, N-acetylcysteine was associated with significant increases in progesterone, endometrial thickness, and LH levels.Meta-analysis, in women with polycystic ovary syndrome. Vina et al., 2025 (Nutrients). PMID 39861414 ↗
- In a randomised trial in 230 women with a diagnosed reproductive condition undergoing ovulation induction, N-acetylcysteine was linked to higher clinical pregnancy rates and required a lower dose and duration of a fertility drug compared to a control group.Randomised trial, in women with polycystic ovary syndrome. Fang et al., 2024 (Journal of Ovarian Research). PMID 39415242 ↗
- In a 3-month randomised trial in 70 adults with a diagnosed inflammatory joint condition, N-acetylcysteine did not improve disease activity scores but did reduce blood levels of nitric oxide and fasting blood sugar and increase HDL ('good') cholesterol compared to a placebo.Randomised trial, in rheumatoid arthritis patients. Esalatmanesh et al., 2022 (Amino Acids). PMID 35133468 ↗
- In a randomised trial in 32 adults with a diagnosed heart condition, oral N-acetylcysteine taken for 3 days reduced levels of three markers of inflammation and immune response.Randomised trial, in patients with acute myocardial infarction (AMI) and ST segment elevation (STEMI) who received fibrinolytic therapy. Wasyanto et al., 2019 (Acta Medica Indonesiana). PMID 32041914 ↗
- This meta-analysis of seven trials in 566 adults with diagnosed substance use or trauma-related conditions found that N-acetylcysteine did not consistently reduce alcohol craving or the severity of trauma symptoms compared to a placebo.Systematic review, in patients with alcohol use disorder (AUD), post-traumatic stress disorder (PTSD), and their co-occurrence. Ahmed et al., 2026 (BMC Psychiatry). PMID 42115982 ↗
- As a feed additive in poultry, N-acetylcysteine reduced markers of ochratoxin A toxicity. A poultry feeding study does not transfer to human dosing.Animal study. Tanveer et al., 2025 (Food Additives and Contaminants Part A). PMID 40803992 ↗
Chosen from the 9,463 we read for Acetylcysteine.
The studies, linked.
12 sources behind our Acetylcysteine verdict, every one linked to PubMed, the journal or ClinicalTrials.gov.
- Meta-analysisEfficacy and safety of acetylcysteine in "non-acetaminophen" acute liver failure: A meta-analysis of prospective clinical trials.PubMed ↗Clinics and research in hepatology and gastroenterology, 2015, cited 80 times
11 more linked trials
- ReviewOxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-AcetylcysteinePubMed ↗International Journal of Molecular Sciences, 2015, cited 231 times, open access
- Clinical trialEffectiveness of Routine Nebulization of Mucolytics and Bronchodilators in Mechanically Ventilated Intensive Care Patients'ClinicalTrials.gov ↗950 participants, Completed
- Clinical trialThe Effect of N-acetylcysteine on Oxidative Stress Status and Iron Overload in Thalassemia MajorClinicalTrials.gov ↗Phase 1, 100 participants, Completed
- Clinical trialN-Acetylcysteine for Neuroprotection in Parkinson's DiseaseClinicalTrials.gov ↗Phase 1, 50 participants, Completed
- Clinical trialA Pilot Randomized Controlled Trial of Intravenous N-acetyl Cysteine in Patients Undergoing Pharmaco-invasive Reperfusion Early After an ST-segment Elevation Myocardial InfarctionClinicalTrials.gov ↗Phase 2, 44 participants, Completed
- Clinical trialOpen-Label Study of N-Acetylcysteine in Children and Adolescents Ages 5-17 With Bipolar I, Bipolar II, and Bipolar Spectrum DisorderClinicalTrials.gov ↗Phase 4, 40 participants, Completed
- Clinical trialN-acetylcysteine Supplementation in Individuals With Low Glutathione Levels: the Effects on Physical Performance and Redox HomeostasisClinicalTrials.gov ↗Phase 2, 36 participants, Completed
- Clinical trialRole of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1): Potential Use of Antioxidant/Anti-inflammatory MedicationsClinicalTrials.gov ↗Phase 2, 33 participants, Completed
- Clinical trialEffect of a Multi-ingredient of L-Histidine, L-Serine, L-Carnosine and N-Acetylcysteine on Visceral Adiposity and Non-alcoholic Fatty Liver Disease in Individuals With Abdominal Obesity. Randomized, Parallel, Placebo Controlled, Triple Blind Study.ClinicalTrials.gov ↗20 participants, Completed
- Clinical trialN-Acetyl Cysteine add-on to Antidepressant Medication in Therapy Refractory Major Depressive Disorder Patients With Increased Inflammatory ActivityClinicalTrials.gov ↗200 participants, Unknown
- Clinical trialRandomized Controlled Clinical Trial of Antioxidant Therapy in Critically Ill Patients With Septic Shock: Analysis Before and After Treatment of the Oxidative StressClinicalTrials.gov ↗Phase 3, 131 participants, Unknown
From clinical trials and PubMed, ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 108,995 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Acetylcysteine is, not how risky it is. A report is not proof Acetylcysteine caused anything. It is a signal of what to watch for, nothing more.
3 more reported effects
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.